Fever Without a Cause: 7 Red Flag Symptoms

Fever Without a Cause: 7 Red Flag Symptoms

Fever is one of the most common and nonspecific signs in clinical medicine, often serving as a sentinel of infection, inflammation, or malignancy. When a patient presents with a fever that lacks an obvious source after initial evaluation, clinicians must consider a broad differential that includes vector-borne infections, autoimmune processes, and occult malignancies. Among the most frequently overlooked causes of unexplained fever is Lyme borreliosis, a multisystem infection caused by spirochetes of the Borrelia burgdorferi sensu lato complex. This article examines seven red flag symptoms that, when accompanied by fever without a clear cause, should prompt consideration of Lyme disease and related tick-borne infections. The discussion draws on epidemiological data, pathophysiological mechanisms, and clinical evidence from the peer-reviewed literature.

The Epidemiology of Unexplained Fever in Lyme Disease

Understanding the epidemiological context of Lyme disease is essential for recognizing when unexplained fever may be attributable to Borrelia infection. Lyme disease is the most common vector-borne illness in the Northern Hemisphere, with an estimated 476,000 cases diagnosed annually in the United States alone, according to the Centers for Disease Control and Prevention. In Europe, the incidence varies widely by region, with some areas reporting rates exceeding 200 cases per 100,000 population per year. The true burden is likely higher, as surveillance systems capture only a fraction of cases due to underdiagnosis, variable reporting standards, and the limitations of serological testing. As Carriveau, Poole, and Thomas (2023) note in their comprehensive review, Lyme disease remains underrecognized in many clinical settings, particularly when patients present with atypical symptoms or lack a clear history of tick exposure. The spirochetes responsible for Lyme disease, including Borrelia burgdorferi, Borrelia afzelii, Borrelia garinii, and Borrelia mayonii, are transmitted through the bite of infected Ixodes ticks. The geographic distribution of these ticks continues to expand, driven by climate change, reforestation, and increasing human encroachment into tick habitats. This expansion has brought Lyme disease into regions previously considered low-risk, complicating the diagnostic process for clinicians who may not consider the infection in patients without a travel history to endemic areas.

The clinical presentation of Lyme disease is notoriously variable, and fever may be the sole manifestation in a subset of patients. In the early localized stage, which typically occurs within days to weeks of a tick bite, fever is often accompanied by erythema migrans, the characteristic bullseye rash. However, as many as 20 to 30 percent of patients do not develop or do not notice this rash, leaving fever as the primary clue. Even when the rash is present, it may be atypical in appearance, particularly in patients infected with European genospecies. Strnad et al. (2023) emphasize that the pathogenicity and virulence of Borrelia species differ, with Borrelia afzelii more commonly associated with cutaneous manifestations and Borrelia garinii with neurological involvement. This heterogeneity means that the absence of a classic rash does not rule out Lyme disease, especially in the context of unexplained fever. Furthermore, the fever in Lyme disease may be low-grade and intermittent, leading patients and clinicians alike to attribute it to a viral illness or other self-limiting condition. The challenge is compounded by the fact that standard two-tier serological testing, which relies on an enzyme immunoassay followed by a Western blot, has limited sensitivity in early disease. During the first few weeks of infection, the immune response may not have produced detectable antibodies, resulting in false-negative tests. This diagnostic gap contributes to the phenomenon of unexplained fever that persists despite initial evaluation.

Red Flag Symptom 1: Fever Accompanied by Migratory Arthralgias

One of the most distinctive red flags for Lyme disease is the combination of fever with migratory arthralgias, or joint pain that moves from one location to another over days to weeks. This pattern reflects the ability of Borrelia spirochetes to disseminate through the bloodstream and localize in synovial tissues. Steere et al. (2016) describe in their comprehensive review that arthritis, particularly of the knee, is a hallmark of late-stage Lyme disease in the United States, but arthralgias without frank arthritis can occur much earlier. The migratory nature of the pain is key; patients may report that their right knee hurts one day, their left shoulder the next, and their wrists the following week. This pattern is distinct from the symmetric polyarthritis of rheumatoid arthritis or the fixed, weight-bearing joint pain of osteoarthritis. The underlying mechanism involves the spirochetes adherence to host extracellular matrix proteins and the subsequent inflammatory response, which includes the recruitment of neutrophils, macrophages, and T cells. The release of pro-inflammatory cytokines such as tumor necrosis factor-alpha and interleukin-1 beta contributes to both fever and joint pain. In the context of an unexplained fever, migratory arthralgias should raise suspicion for disseminated Lyme disease, even in the absence of a known tick bite or rash. Clinicians should also consider co-infections such as anaplasmosis or babesiosis, which are transmitted by the same tick vector and can present with similar symptoms.

The epidemiological significance of this symptom cannot be overstated. In a study of patients with early disseminated Lyme disease, approximately 60 percent reported arthralgias at some point during their illness, and fever was present in a similar proportion. The overlap between these symptoms and those of other rheumatic conditions, such as palindromic rheumatism or seronegative spondyloarthropathy, often leads to diagnostic delays. Wong, Shapiro, and Soffer (2022) note in their review of post-treatment Lyme disease syndrome that patients with unrecognized Lyme arthritis may undergo extensive rheumatological workups before the correct diagnosis is made. This delay has public health implications, as untreated Lyme disease can progress to chronic neurological or cardiac complications. From a pathophysiological perspective, the migratory pattern of arthralgias is thought to reflect the spirochetes ability to evade the immune system through antigenic variation and the formation of biofilms. These biofilms, composed of spirochetes embedded in a protective matrix of polysaccharides and host proteins, allow the bacteria to persist in tissues despite antibiotic therapy. The presence of fever alongside migratory arthralgias may indicate active dissemination and should prompt immediate consideration of antibiotic treatment, even before serological confirmation is available.

Red Flag Symptom 2: Fever with Neurological Symptoms

Neurological involvement in Lyme disease, known as neuroborreliosis, represents a serious manifestation that can present with fever as a key component. The classic triad of lymphocytic meningitis, cranial neuritis, and radiculoneuritis is well described in the European literature, where Borrelia garinii is a common cause. However, in North America, neurological symptoms may be more subtle, including headache, cognitive fog, and peripheral neuropathy. Kullberg et al. (2020) outline in their clinical practice guidelines that fever is present in a majority of patients with early neuroborreliosis, often accompanying a stiff neck, photophobia, and fluctuating mental status. The red flag here is the combination of fever with new-onset neurological deficits, such as facial palsy, which occurs in approximately 10 to 15 percent of Lyme disease cases. Bilateral facial palsy is particularly suggestive of Lyme disease, as it is rare in other conditions. The mechanism involves direct invasion of the central nervous system by spirochetes, which cross the blood-brain barrier and trigger an inflammatory response. The resulting lymphocytic pleocytosis in the cerebrospinal fluid is diagnostic, but lumbar puncture is not always performed in the initial evaluation of unexplained fever.

From an epidemiological standpoint, neuroborreliosis accounts for a significant proportion of Lyme disease cases in Europe, where rates of neurological involvement are higher than in the United States. Marques, Strle, and Wormser (2021) compare the clinical presentations across continents and note that while arthritis is more common in American patients, neurological symptoms predominate in European cohorts. This difference is attributable to the genospecies of Borrelia circulating in each region. For the clinician evaluating a patient with unexplained fever and neurological symptoms, a history of travel to endemic areas is critical. However, the expanding range of Ixodes ticks means that even patients without a travel history may be at risk. The red flag of fever with neurological symptoms also applies to post-treatment Lyme disease syndrome, where persistent cognitive complaints and fatigue are accompanied by low-grade fever in some patients. Wong, Shapiro, and Soffer (2022) caution that while objective neurological findings are less common in this syndrome, the subjective experience of fever and brain fog can be debilitating. The pathophysiological basis for these symptoms is not fully understood but may involve ongoing immune dysregulation, autoimmunity, or the persistence of spirochete antigens in the central nervous system. Clinicians should maintain a high index of suspicion for Lyme disease in any patient presenting with fever and unexplained neurological findings, particularly when standard tests for viral or bacterial meningitis are negative.

Red Flag Symptom 3: Fever with Cardiac Manifestations

Cardiac involvement in Lyme disease, known as Lyme carditis, is a rare but potentially life-threatening complication that can present with fever as a red flag. The most common cardiac manifestation is atrioventricular block, which can range from first-degree to complete heart block. Steere et al. (2016) report that Lyme carditis occurs in approximately 1 to 4 percent of untreated Lyme disease cases in the United States, with a higher incidence in younger patients. The hallmark symptom is syncope or near-syncope, often accompanied by palpitations, chest discomfort, and dyspnea. Fever is present in the majority of these patients, reflecting the systemic inflammatory response. The mechanism involves direct invasion of the myocardium by Borrelia spirochetes, leading to inflammation and edema in the conduction system. The resulting block is typically reversible with appropriate antibiotic therapy, but without prompt recognition, it can progress to complete heart block and cardiac arrest. The red flag here is the combination of fever with cardiovascular symptoms in a patient without known heart disease, particularly if they live in or have traveled to a Lyme-endemic area.

Epidemiological data on Lyme carditis are limited by underdiagnosis, but case series suggest that it is more common in males and in patients with early disseminated disease. The condition can occur within weeks of the initial tick bite, often before the development of arthritis or neurological symptoms. Kullberg et al. (2020) emphasize that electrocardiographic abnormalities, particularly prolonged PR interval, should prompt consideration of Lyme carditis in the appropriate clinical context. The public health implications are significant, as sudden cardiac death due to unrecognized Lyme carditis has been reported. In one autopsy series, Borrelia spirochetes were identified in myocardial tissue from individuals who died suddenly and unexpectedly, highlighting the need for heightened awareness. For the clinician, the presence of fever with new-onset heart block or unexplained syncope should trigger a thorough history for tick exposure and consideration of Lyme serology. The diagnostic workup should include an electrocardiogram, echocardiogram, and, if indicated, a Lyme-specific antibody test. Treatment with intravenous ceftriaxone or oral doxycycline is highly effective, and most patients recover normal conduction within days to weeks. However, delays in diagnosis can lead to permanent pacemaker implantation or fatal outcomes, making this red flag one of the most critical to recognize.

Red Flag Symptom 4: Fever with Headache and Neck Stiffness

The combination of fever, headache, and neck stiffness is classic for meningitis, and in the context of unexplained fever, it should raise suspicion for Lyme neuroborreliosis. Unlike viral or bacterial meningitis, Lyme meningitis often has a subacute onset, with symptoms evolving over days to weeks. The headache is typically diffuse and may be accompanied by photophobia, phonophobia, and nausea. Neck stiffness is present but may be less severe than in bacterial meningitis, leading to a lower index of suspicion. Strnad et al. (2023) describe how Borrelia garinii, the predominant neurotropic genospecies in Europe, has a particular affinity for the meninges and nerve roots. In North America, Borrelia burgdorferi can also cause meningitis, though it is less common. The red flag here is the persistence of these symptoms despite negative routine cultures and viral testing. Patients may undergo multiple emergency department visits before the correct diagnosis is made, particularly if lumbar puncture is not performed or if cerebrospinal fluid analysis shows only a mild lymphocytic pleocytosis.

From an epidemiological perspective, Lyme meningitis accounts for a substantial proportion of aseptic meningitis cases in endemic areas during the summer months. Carriveau, Poole, and Thomas (2023) note that in some European studies, up to 30 percent of patients with aseptic meningitis have serological evidence of Lyme disease. The overlap with enteroviral meningitis, which also peaks in summer, complicates the clinical picture. However, the presence of radicular pain, cranial nerve palsies, or a history of erythema migrans can help differentiate Lyme meningitis from viral causes. The pathophysiological mechanism involves the migration of spirochetes from the bloodstream into the cerebrospinal fluid, where they trigger an immune response characterized by lymphocytosis and elevated protein levels. The fever in Lyme meningitis is typically low-grade, rarely exceeding 102 degrees Fahrenheit, and may be intermittent. This pattern can lead clinicians to attribute the symptoms to a viral syndrome, delaying appropriate treatment. For the patient, the consequences of untreated Lyme meningitis can include chronic headache, cognitive impairment, and the development of encephalomyelitis. The red flag of fever with headache and neck stiffness should therefore prompt a careful evaluation for Lyme disease, including a thorough travel and exposure history, serological testing, and, if indicated, lumbar puncture with Borrelia-specific polymerase chain reaction or antibody index testing.

Red Flag Symptom 5: Fever with Fatigue and Malaise

Fatigue and malaise are among the most common complaints in primary care, and when accompanied by fever, they often lead to a diagnosis of a viral illness. However, in the context of Lyme disease, these symptoms can be profound and persistent, lasting for weeks or months. The red flag here is the severity and duration of the fatigue, which is often described by patients as overwhelming and unlike anything they have experienced before. Wong, Shapiro, and Soffer (2022) discuss how post-treatment Lyme disease syndrome is characterized by debilitating fatigue, cognitive dysfunction, and pain, with fever present in a subset of patients. The underlying mechanisms are complex and involve both direct effects of the spirochete and the host immune response. Borrelia burgdorferi has been shown to induce a Th1-dominant immune response, with elevated levels of interferon-gamma and tumor necrosis factor-alpha, which contribute to systemic symptoms such as fever and fatigue. Additionally, the spirochete can persist in tissues in the form of round bodies or biofilms, leading to chronic immune activation and metabolic dysregulation.

From an epidemiological standpoint, the prevalence of Lyme disease among patients presenting with chronic fatigue is not well established, but studies suggest that a small percentage of patients with chronic fatigue syndrome have serological evidence of past or current Borrelia infection. The challenge for clinicians is distinguishing Lyme-related fatigue from other causes, such as Epstein-Barr virus infection, autoimmune diseases, or depression. The presence of fever, even if low-grade and intermittent, is a crucial distinguishing feature. In a study of patients with early Lyme disease, over 80 percent reported fatigue, and approximately 40 percent had documented fever. The combination of fever with severe fatigue that interferes with daily activities should prompt consideration of Lyme disease, particularly if the patient lives in or has traveled to an endemic area. The public health implications are significant, as untreated Lyme disease can lead to chronic disability and reduced quality of life. Early recognition and treatment with appropriate antibiotics can prevent progression to the post-treatment syndrome, though some patients continue to experience symptoms despite adequate therapy. For these individuals, the red flag of fever with fatigue may represent ongoing immune dysregulation rather than active infection, and management should focus on symptom control and supportive care.

Red Flag Symptom 6: Fever with Lymphadenopathy

Lymphadenopathy, or swollen lymph nodes, is a common finding in many infectious and inflammatory conditions, but when accompanied by fever in the absence of an obvious source, it should raise suspicion for Lyme disease. In the early localized stage, lymphadenopathy may occur near the site of the tick bite, often in the axilla, groin, or neck. As the infection disseminates, generalized lymphadenopathy can develop, reflecting the systemic spread of spirochetes through the lymphatic system. Steere et al. (2016) note that lymphadenopathy is present in approximately 20 to 30 percent of patients with early Lyme disease, and it is often accompanied by fever, headache, and myalgias. The red flag here is the presence of tender, mobile lymph nodes that are not explained by a localized infection such as pharyngitis or dental abscess. The mechanism involves the trafficking of Borrelia spirochetes to regional lymph nodes, where they are processed by dendritic cells and macrophages, leading to B cell and T cell activation. This immune response generates the characteristic lymphadenopathy and contributes to the production of antibodies that are detected in serological tests.

Epidemiological data on Lyme disease and lymphadenopathy are limited, but case reports highlight the potential for misdiagnosis. Patients with Lyme-related lymphadenopathy may undergo unnecessary biopsies or imaging studies for suspected lymphoma or metastatic cancer. Marques, Strle, and Wormser (2021) caution that the clinical presentation of Lyme disease can mimic a wide range of conditions, including viral infections, autoimmune diseases, and malignancies. The presence of fever with lymphadenopathy should prompt a careful examination for erythema migrans, which may be inconspicuous or located in a hidden area such as the scalp or perineum. A thorough history of tick exposure, including recent outdoor activities, is essential. The public health implications of misdiagnosis include delayed treatment and the potential for disease progression to neurological or cardiac complications. For the clinician, the evaluation of unexplained fever with lymphadenopathy should include Lyme serology, particularly in endemic areas. The sensitivity of serological testing is higher in disseminated disease, but false negatives can still occur in early infection. In such cases, a clinical diagnosis based on the combination of fever, lymphadenopathy, and a compatible exposure history may justify empiric antibiotic therapy.

Red Flag Symptom 7: Fever with Cognitive Changes

Cognitive changes, including memory loss, difficulty concentrating, and mental fog, are increasingly recognized as manifestations of Lyme disease, particularly in the context of neuroborreliosis. When these symptoms are accompanied by fever, they constitute a red flag that should prompt a thorough evaluation for Lyme disease and other tick-borne infections. Kullberg et al. (2020) describe how cognitive impairment in Lyme disease can range from subtle executive dysfunction to frank encephalopathy, with fever serving as a marker of active inflammation. The mechanism involves the direct effects of spirochetes on the central nervous system, as well as the indirect effects of systemic inflammation. Borrelia burgdorferi has been shown to induce the release of pro-inflammatory cytokines that cross the blood-brain barrier and disrupt neuronal function. Additionally, the spirochete can trigger autoimmune responses, with antibodies directed against host neural antigens contributing to cognitive deficits. The red flag here is the acute or subacute onset of cognitive changes in a patient with fever, particularly if they have no prior history of dementia or psychiatric illness.

From an epidemiological perspective, the prevalence of cognitive symptoms in Lyme disease is difficult to quantify due to the subjective nature of the complaints and the lack of standardized assessment tools. However, studies of patients with post-treatment Lyme disease syndrome consistently report cognitive dysfunction as a major source of disability. Wong, Shapiro, and Soffer (2022) note that up to 50 percent of patients with chronic Lyme symptoms report cognitive difficulties, and a subset of these patients have objective deficits on neuropsychological testing. The presence of fever in these patients may indicate ongoing active infection or immune activation, though the relationship is complex. For the clinician, the evaluation of unexplained fever with cognitive changes should include a comprehensive neurological examination, magnetic resonance imaging of the brain, and cerebrospinal fluid analysis. In Lyme disease, imaging may show white matter hyperintensities or meningeal enhancement, while cerebrospinal fluid analysis may reveal lymphocytic pleocytosis and elevated protein levels. The public health implications are significant, as untreated neuroborreliosis can lead to permanent cognitive impairment and reduced quality of life. Early recognition and treatment with antibiotics can improve outcomes, but some patients continue to experience residual deficits. The red flag of fever with cognitive changes therefore serves as a critical prompt for timely intervention.

Conclusion: Integrating the Red Flags into Clinical Practice

The seven red flag symptoms discussed in this article fever with migratory arthralgias, neurological symptoms, cardiac manifestations, headache and neck stiffness, fatigue and malaise, lymphadenopathy, and cognitive changes represent key clinical clues that should alert clinicians to the possibility of Lyme disease in patients with unexplained fever. The epidemiological context is essential; Lyme disease is expanding geographically, and its clinical presentation is highly variable, depending on the infecting genospecies and the host immune response. Standard diagnostic tests have limitations, particularly in early disease, and a high index of suspicion is necessary to avoid delays in treatment. The consequences of unrecognized Lyme disease can be severe, including chronic arthritis, neurological deficits, cardiac complications, and persistent symptoms that impair quality of life. From a public health perspective, improving awareness of these red flags among clinicians and the general public is critical for reducing the burden of this increasingly common infection. Future research should focus on developing more sensitive diagnostic tools, understanding the mechanisms of persistent symptoms, and identifying effective treatment strategies for patients who do not respond to standard antibiotic therapy. In the meantime, the red flags outlined here provide a practical framework for integrating Lyme disease into the differential diagnosis of unexplained fever, ultimately improving patient outcomes and reducing the long-term impact of this complex and challenging disease.